Methylene Blue vs. Asthma: Can a Redox Molecule Calm Inflammation & Oxidative Stress?

About this episode

Dr. Mike discusses the effects of methylene blue on asthma-related inflammation and oxidative stress based on a preclinical study.

In this Energy Code Deep Dive, Dr. Mike breaks down a preclinical paper testing methylene blue in a classic ovalbumin (OVA)–induced allergic asthma mouse model. The core question: if allergic asthma is driven by a self-reinforcing loop of TH2 cytokines (IL-4, IL-13), IgE signaling, eosinophilic airway infiltration, and oxidative stress, can a redox-active compound interrupt the cycle? The study reports dose-dependent improvements across airway inflammation (BALF immune cells), immune programming (IL-4/IL-13 + OVA-specific IgE), oxidative damage (MDA), antioxidant defenses (GSH/GPx), and lung histology — while emphasizing the key caveat: this is not human clinical asthma, and safety/translation questions remain open. (Educational content only, not medical advice.) - Article Discussed in Episode: Methylene blue attenuates ovalbumin-induced airway inflammation and oxidative stress in mouse model of asthma - Key Quotes From Dr. Mike: “Oxidative stress is not a side issue in asthma, it is part of the disease mechanism.” “Eosinophilia is one of the hallmarks of allergic asthma.” “Methylene blue significantly reduced those IgE levels… in a dose-dependent manner.” “Both cytokines were…

People in this episode

Host: Dr. Mike Belkowski

Topics covered

• methylene blue
• asthma
• oxidative stress
• inflammation
• TH2 cytokines

Keywords

• methylene blue
• asthma
• oxidative stress
• TH2 cytokines
• inflammation

Mentioned in this episode

Products: methylene blue

Books & works: Methylene blue attenuates ovalbumin-induced airway inflammation and oxidative stress in mouse model of asthma

More episodes of The Energy Code

• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 2 · June 11, 2026 · 58 min
• MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience · June 8, 2026 · 31 min
• SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source · June 5, 2026 · 15 min
• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1 · June 4, 2026 · 1h 2m
• Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse · June 3, 2026 · 21 min
• The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch · June 2, 2026 · 15 min